Monitor for potential improvements in commercial execution and sales performance under new leadership, particularly in systems and services sales. The appointment signals focus on strengthening commercial performance but does not represent an immediate financial catalyst.
Price Chart
Executive Summary
Accuray announced the appointment of Paul Miele as Senior Vice President and Chief Commercial Officer, effective April 6, 2026. Miele brings extensive commercial leadership experience from Johnson & Johnson MedTech, Globus Medical, and Intuitive Surgical to lead Accuray's global commercial organization.
Key Facts
- Paul Miele appointed SVP and Chief Commercial Officer effective April 6, 2026
- Miele previously served as Business Unit Leader and General Manager for the MONARCH robotic platform at Johnson & Johnson MedTech
- He has nearly two decades of experience in global capital medical device businesses across the Americas, EMEA, and APAC
- Miele will lead Accuray's global commercial organization and commercialization strategy
Financial Impact
No immediate financial impact disclosed
Risk Factors
- Integration risk with new executive leadership
- Potential disruption during leadership transition
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-011313 |
| Exhibit: ex_941350.htm | 0001437749-26-011313 |
| Document: 0001437749-26-011313-index-headers.html | 0001437749-26-011313 |
| Document: 0001437749-26-011313-index.html | 0001437749-26-011313 |
| Document: 0001437749-26-011313.txt | 0001437749-26-011313 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 6d ago | Press Release | $0.1340 | awaiting T+5 | — | $0.1331 (−0.67%) |
Oct 16, 2026 10d ago | DEF 14A | $0.1400 $0.1250 | ▲ +10.71% | ▲ +10.57% | $0.1331 (+4.93%) |
Oct 13, 2026 14d ago | 8-K | $0.1751 $0.1370 | ▼ −21.76% | ▼ −22.21% | $0.1331 (−23.99%) |
Oct 7, 2026 20d ago | 3 | $0.2414 $0.1738 | ▼ −28.00% | ▼ −27.73% | $0.1331 (−44.86%) |
Oct 6, 2026 21d ago | 8-K | $0.2534 $0.1751 | ▲ +30.90% | ▲ +29.92% | $0.1331 (+47.47%) |
Sep 27, 2026 4w ago | Press Release | $0.2998 $0.3017 | ▲ +0.63% | ▼ −0.57% | $0.1331 (−55.60%) |
Sep 22, 2026 5w ago | Institutional Cluster | $0.2300 $0.3000 | ▲ +30.43% | ▲ +31.62% | $0.1331 (−42.13%) |
Sep 14, 2026 6w ago | EFFECT | $0.2453 $0.2400 | ▲ +2.16% | ▲ +2.27% | $0.1331 (+45.74%) |
Sep 11, 2026 6w ago | Press Release | $0.2502 $0.2336 | ▼ −6.63% | ▼ −6.41% | $0.1331 (−46.80%) |
Aug 19, 2026 9w ago | Press Release | $0.2924 $0.2621 | ▲ +10.36% | ▲ +11.48% | $0.1331 (+54.48%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers